CD274 and metastatic neoplasm: Other tested variables, such as age, initial tumor phenotype at early stage, disease type (recurrence versus de novo metastatic disease), the number of sites of metastatic disease, metastatic sites, previous treatment with chemotherapy, previous taxane exposure, PD-L1 level or BRCA mutation status had no significant impact.